Best Stock Options this May 2026

Moderna Inc. (MRNA) has demonstrated a strong performance with an impressive 84.74% return over the past year, though it has seen a significant decline of 72.34% over the past five years. Analysts maintain a neutral outlook with a median 12-month price target of $35.00, reflecting cautious optimism amidst fluctuating valuations that range from $17.00 to $63.00. With a consensus rating of C, this stock remains an intriguing option for investors closely monitoring the biotech sector.

MRNA has a neutral consensus from 30 Wall Street analysts, with a median price target of $40.50, indicating a potential downside of 20.5% from its current trading price of $50.96.

Mersana Therapeutics (MRSN) has a consensus Buy rating from 2 analysts.

Texas Pacific Land Corp. (TPL) has demonstrated impressive growth, boasting a 146.19% return over the past five years, significantly outperforming the S&P 500. Currently, analysts maintain a "Buy" consensus, with a 12-month price target set at $639, reflecting strong confidence in the stock's continued upward trajectory. With a modest dividend yield of 0.41%, TPL remains an attractive option for investors seeking exposure to high-performing assets in the market.

Texas Pacific Land (TPL) has outperformed the S&P 500, gaining 148% over the past five years and 36.4% in the last six months.

TPL has a consensus rating of 'Buy' from analysts.

TPL's stock has appreciated by approximately 30.76% since coverage began, and its unique business model suggests strong long-term wealth compounding potential.

Sandisk Corp. (SNDK) stands out as a top performer, boasting an impressive 1-year return of 2967.55% and a 5-year return of 2649.72%. Analysts have a median 12-month price target of $737.50, with a range spanning from $220.00 to $1400.00, highlighting a strong interest in the stock as 16 out of 21 analysts recommend a "Strong Buy." Investors seeking high-growth opportunities may find Sandisk an attractive option, given its exceptional performance and positive analyst outlook. While some analysts suggest it could be overvalued at $932.43, the SWS DCF model indicates a potential future cash flow value of $2,833.85, pointing to robust profitability prospects.

Of the 21 analysts covering Sandisk, 16 recommend a 'Strong Buy,' one a 'Moderate Buy,' and four a 'Hold,' with an average price target of $916.47, above the current price of about $903.

The average 1-year price target for SNDK is $779.22, with forecasts ranging from a low of $252.50 to a high of $1,050.

Analysts suggest Sandisk may be overvalued at $932.43 compared to a fair value of $264.95, but a DCF model indicates shares are trading at a 67.1% discount based on future cash flow.

The average twelve-month price target for Sandisk is $752.48, with a high of $1,250.00 and a low of $63.00, indicating a potential downside of 19.30% from the current price of $932.43.

Microsoft Corp. (MSFT) stands out with a strong analyst buy rating and is recognized as an undervalued stock in the U.S. market. With a solid 1-year return of 8.55% and a remarkable 5-year return of 62.08%, it presents an attractive option for investors seeking long-term growth. Analysts have set a median price target of $585, indicating strong confidence in the stock's future performance.

Microsoft (MSFT) has a consensus rating of Buy from 31 analysts, with 35% recommending a Strong Buy and 58% a Buy.

Critics argue that Microsoft is experiencing slowing momentum in its subscription shift, particularly in Office, and lacks a strong mobile presence, while also not leading in key growth areas like Azure and Dynamics.

Analysts estimate Microsoft's fair value to be around USD 600 per share by 2026, indicating the stock is currently undervalued.

A $10,000 investment in Microsoft 10 years ago would have grown to approximately $111,617 based on current share prices, not including dividends received.